Quarterly report [Sections 13 or 15(d)]

BUSINESS (Details Narrative)

v3.25.1
BUSINESS (Details Narrative) - BioCorRx Pharmaceuticals, Inc [Member]
Jul. 28, 2016
Management fee 24.20%
Ownership retained percent 75.80%